Understanding the complex three-way communication between immune cells, the gut microbiome, and cancer sheds light on why immunotherapies fail in some patients but succeed in others.
As global regulations shift toward animal-free testing, how can researchers develop more biologically relevant in vitro models to advance drug discovery?